Otros idiomas Faron Pharmaceuticals Oy

Acciones

Mercado cerrado - London S.E. Otros sitios de cotización 17:35:21 31/05/2024			Varia. Cinco días.	Varia. 1 de enero.
185 ^GBX	+4,23 %		-3,90 %	-39,34 %

22/05	Transcript : Faron Pharmaceuticals Oy - Special Call
20/05	El combo contra el cáncer de sangre de Faron Pharmaceuticals demuestra su eficacia en un estudio de fase intermedia	MT

Transcript : Faron Pharmaceuticals Oy - Special Call	22/05
Faron Pharmaceuticals’ Blood Cancer Combo Shows Efficacy in Mid-stage Study	20/05
Faron Pharma celebrates positive read-out in ongoing MDS trial	20/05
Faron Pharmaceuticals Ltd. Provides First Data from Phase 2 of BEXMAB	20/05
Kelso raises stake in NCC; Transense joins project	03/05
Faron Pharmaceuticals Ltd. Announces Appointment of Dr. Juho Jalkanen as Director	30/04
Faron Pharmaceuticals Oy Announces Chief Executive Officer Changes	30/04
Faron Pharmaceuticals Oy Confirms Plans for the Coming Months	16/04
Faron Pharmaceuticals reappoints former finance chief on interim basis	15/04
Faron Pharmaceuticals promotes COO to CEO as father retires	08/04
Faron Pharmaceuticals promotes COO to CEO as founder steps back	08/04
Faron Pharmaceuticals CEO to Retire, COO Named Successor	08/04
Faron Pharmaceuticals Elects New Chair	08/04
Faron Pharmaceuticals Oy Announces Board Changes	08/04
Faron Pharmaceuticals Ltd. Announces Chief Executive Officer Changes	08/04
Faron Pharmaceuticals secures funding to deliver next "milestones"	04/04
Faron Pharmaceuticals Raises EUR5 Million via Share Placement	04/04
Quiz sales fall, names new CEO; Byotrol eyes AIM exit	03/04
Transcript : Faron Pharmaceuticals Oy - Special Call	19/03
Stocks downbeat before central bank rate storm	18/03

No hay resultados para esta búsqueda